Publications

Healthcare & Life Sciences

US Hereditary Angioedema Association (HAEA)

Development and validation of a US quality of life instrument for hereditary angioedema due to C1 inhibitor deficiency

Postal & Delivery

Shein

Study on the EU proposed customs duty de minimis removal

TMT & Digital

Copenhagen Economics

VODAFONE/3 UK: Signs of A new playbook for mobile mergers?

Healthcare & Life Sciences

PhRMA

Regulatory data protection for pharmaceuticals – How implementing RDP in China will benefit society, industry and the Chinese economy

Competition

Advokatrådet (The Danish Bar and Law Society)

Legal security in Greenland – What are the funding needs associated with implementing Advokatrådets recommendations?

Competition

Copenhagen Economics

The price-cost test in the Art 102 new draft guidelines: when and how to use it

Competition

Copenhagen Economics

Generative AI Partnerships: Separating Good from Bad

Competition

Copenhagen Economics

The Road Becomes Clearer

TMT & Digital

Copenhagen Economics

Cloud on the regulatory horizon? A time of reckoning for the EU telecoms industry

Healthcare & Life Sciences

European Federation of Pharmaceutical Industries and Associations (EFPIA)

Cost and value of regulatory data protection

Healthcare & Life Sciences

EURORDIS, Alexion AstraZeneca Rare Disease, Takeda, Orphanet

Enabling, not rewarding: How to design a high unmet medical needs category to drive, not deter, innovation in orphan medicinal products

TMT & Digital

Copenhagen Economics

Reduced regulation for telecoms? A time of reckoning for the EU telecoms industry

Healthcare & Life Sciences

Novartis Healthcare A/S

Real-world evidence on the economic implications of CGRP inhibitors as preventive treatment of migraine in Denmark

Competition

Copenhagen Economics

Quality: A game changer in market definition?

Healthcare & Life Sciences

OD Expert Group

European Union Health Technology Assessment Fit for Rare Diseases

TMT & Digital

Computer & Communications Industry Association (CCIA Europe)

Development and validation of a US quality of life instrument for hereditary angioedema due to C1 inhibitor deficiency

Study on the EU proposed customs duty de minimis removal

VODAFONE/3 UK: Signs of A new playbook for mobile mergers?

Regulatory data protection for pharmaceuticals – How implementing RDP in China will benefit society, industry and the Chinese economy

Legal security in Greenland – What are the funding needs associated with implementing Advokatrådets recommendations?

The price-cost test in the Art 102 new draft guidelines: when and how to use it

Generative AI Partnerships: Separating Good from Bad

The Road Becomes Clearer

Cloud on the regulatory horizon? A time of reckoning for the EU telecoms industry

Cost and value of regulatory data protection

Enabling, not rewarding: How to design a high unmet medical needs category to drive, not deter, innovation in orphan medicinal products

Reduced regulation for telecoms? A time of reckoning for the EU telecoms industry

Real-world evidence on the economic implications of CGRP inhibitors as preventive treatment of migraine in Denmark

Quality: A game changer in market definition?

European Union Health Technology Assessment Fit for Rare Diseases

Generative Artificial Intelligence: the Competitive Landscape